Coronapod: The divisive hydroxychloroquine study that's triggering mass confusion from Nature Podcast

From Nature Podcast - 00:59 Chloroquine on rocky ground President Trump's preferred coronavirus treatment is the focus of a new study suggesting it could cause more harm than good, but not everybody agrees. We discuss the fallout as trials around the world are paused and countries diverge over policy advice. News: India expands use of controversial coronavirus drug amid safety concerns News: Safety fears over hyped drug hydroxychloroquine spark global confusion 12:12 Are we rushing science? Coronavirus papers are being published extremely quickly, while normally healthy scientific debate is being blown up in the world's press. Is there a balancing act between timely research and accurate messaging? 18:49 One good thing Our hosts pick out things that have made them smile in the last week, including hedgerow brews and a trip into the past using AI. Recipe: Elderflower 'Champagne' Video: Denis Shiryaev restores historic footage with AI 22:30 The latest coronavirus research papers Noah Baker takes a look through some of the key coronavirus papers of the last few weeks. News: Coronavirus research updates medRxiv: Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel Harvard Library: Reductions in commuting mobility predict geographic differences in SARS-CoV-2 prevalence in New York City Science: DNA vaccine protection against SARS-CoV-2 in rhesus macaques  See acast.com/privacy for privacy and opt-out information.
Coronapod: The divisive hydroxychloroquine study that's triggering mass confusion
2020-05-29 10:58:37
00:59 Chloroquine on rocky ground President Trump's preferred coronavirus treatment is the focus of a new study suggesting it could cause more harm than good, but not everybody agrees. We discuss the fallout as trials around the world are paused and countries diverge over policy advice. News: India expands use of controversial coronavirus drug amid safety concerns News: Safety fears over hyped drug hydroxychloroquine spark global confusion 12:12 Are we rushing science? Coronavirus papers are being published extremely quickly, while normally healthy scientific debate is being blown up in the world's press. Is there a balancing act between timely research and accurate messaging? 18:49 One good thing Our hosts pick out things that have made them smile in the last week, including hedgerow brews and a trip into the past using AI. Recipe: Elderflower 'Champagne' Video: Denis Shiryaev restores historic footage with AI 22:30 The latest coronavirus research papers Noah Baker takes a look through some of the key coronavirus papers of the last few weeks. News: Coronavirus research updates medRxiv: Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel Harvard Library: Reductions in commuting mobility predict geographic differences in SARS-CoV-2 prevalence in New York City Science: DNA vaccine protection against SARS-CoV-2 in rhesus macaques  See acast.com/privacy for privacy and opt-out information.

26 minutes, 37 seconds

More Episodes from Nature Podcast

The Nature Podcast brings you the best stories from the world of science each week. We cover everything from astronomy to neuroscience, highlighting the most exciting research from each issue of Nature journal. We meet the scientists behind the results and providing in-depth analysis from Nature's journalists and editors.

Audio long-read: Thundercloud Project tackles a gamma-ray mystery
Researchers in Japan are trying to understand why thunderstorms fire out bursts of powerful radiation  See acast.com/privacy for privacy and opt-out information.

Coronapod: our future with an ever-present coronavirus
What's the endgame for the COVID-19 pandemic? Is a world without SARS-CoV-2 possible, or is the virus here to stay?  See acast.com/privacy for privacy and opt-out information.

A mammoth discovery: oldest DNA on record from million-year-old teeth
Researchers sequence the oldest DNA ever recovered, and the people bringing art and science together.  See acast.com/privacy for privacy and opt-out information.

Coronapod: Is mixing COVID vaccines a good idea?
The science behind how and when to give vaccines doses. But what does the science say? In this week's episode of Coronapod, we discuss mixing and matching vaccines and lengthening the time between doses. Approaches like these could ease logistical concerns, but we ask what's known about their...

Human Genome Project - Nature's editor-in-chief reflects 20 years on
Looking back at the publication of the human genome, and how macrophages mend muscle.  See acast.com/privacy for privacy and opt-out information.

Coronapod: Variants - what you need to know
Researchers are scrambling to understand the biology of new coronavirus variants and the impact they might have on vaccine efficacy.  See acast.com/privacy for privacy and opt-out information.

Mysterious einsteinium spills its secrets
Exploring the properties of a vanishingly-rare man-made element, and the AI that generates new mathematical conjectures.  See acast.com/privacy for privacy and opt-out information.

Coronapod: Fixing the world's pandemic alarm
A year ago the WHO's coronavirus emergency alarm was largely ignored. Why? News: Why did the world's pandemic warning system fail when COVID hit?  See acast.com/privacy for privacy and opt-out information.

Audio long-read: Push, pull and squeeze - the hidden forces that shape life
Researchers are probing the subtle physical forces that sculpt cells and bodies. This is an audio version of our feature: The secret forces that squeeze and pull life into shape  See acast.com/privacy for privacy and opt-out information.

How a spinal device could relieve a neglected effect of cord injury
A neuroprosthetic device restores blood-pressure control after spinal-cord injury, and identifying the neurons that help us understand others' beliefs.  See acast.com/privacy for privacy and opt-out information.

Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.